Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 3 Profile plot of angiographic response to mibefradil. The Thrombolysis In Myocardial Infarction (TIMI) frame counts were assessed by two blinded independent observers immediately before and 30 min after a single oral 50 mg mibefradil dose in 10 patients with the coronary slow flow phenomenon (CSFP). Mibefradil selectively improved the angiographic response in the 18 vessels initially exhibiting the CSFP (A) (p < 0.005) and had little effect in the 12 vessels with TIMI-3 flow (B).
|
